Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevelamer Carbonate Tablets in Chinese Hemodialysis Patients With Hyperphosphatemia
CTR20140773Phase 3Completed
- Sponsor
- Nanjing Hengsheng Pharmaceutical
- Start
- Jun 2015
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of sevelamer carbonate in hyperphosphatemia, sponsored by Nanjing Hengsheng Pharmaceutical. Started Jun 2015; status: completed.
02
Drugs
sevelamer carbonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on CTR20140773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140773.